Skip to main content

Table 2 Base-case cost estimates ($, year 2013 values) and utilities

From: Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy

Parameter

Median

Range

Description and reference

Costs

   

Cost of capecitabine per 500 mg

6.6

Fixed

Local charge

Cost of S-1 per 20 mg

9.6

7.9 - 10.1

Local charge

Cost of oxaliplatin per 50 mg

88.9

77.3 - 464.5

Local charge

Cost of follow-up per unit

56.5

42.3 - 70.6

Calculation

Cost of tests per 6-weeks of adjuvant with S-1

197.8

15.9 - 317.5

[31]

Cost of salvage chemotherapy per 3-week cycle

2334.6

1429.3 - 3323.2

Calculation

Cost of palliative end-of-life care

1460.3

1055.3 - 2085.7

Calculation

Cost of supportive care per cycle

115.2

31.7 - 317.5

Calculation

Cost of ADR per 6-week period of adjuvant with S-1

42.3

7.9 - 79.4

[31]

Cost of ADR per 3-week cycle of adjuvant with XELOX strategy

68.9

15.9 - 158.7

[31]

Cost of hospitalization per 3-week cycle of adjuvant with XELOX strategy

373

238.1 - 793.7

[31]

Utilities

   

Utility of disease-free survival

0.88

0.8 - 0.97

Measured

Utility of recurrent disease

0.42

0.28 - 0.63

Measured

  1. Key: “&” Values were measured by time trade-off (TTO).